Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
72606
Strengths
Ustekinumab 45 mg/.5mL; Denosumab 60 mg/mL; Denosumab 120 mg/1.7mL; Omalizumab 75 mg/.5mL; Omalizumab 150 mg/mL; Omalizumab 300 mg/2mL; Tocilizumab 162 mg/.9mL; Tocilizumab 80 mg/4mL; Tocilizumab 200 mg/10mL; Tocilizumab 400 mg/20mL; Ustekinumab 90 mg/mL; Ustekinumab 130 mg/26mL; Infliximab-dyyb 120 mg/mL; Bevacizumab 100 mg/4mL; Bevacizumab 400 mg/16mL
Dosage forms
Injection, Solution, Injection, Kit
Routes
Subcutaneous, Intravenous
Drug classes (FDA established)
Interleukin-12 Antagonist, Interleukin-23 Antagonist, Interleukin-6 Receptor Antagonist, RANK Ligand Inhibitor, Anti-IgE, Vascular Endothelial Growth Factor Inhibitor, Tumor Necrosis Factor Blocker
Package NDCs
65

NDC codes

Newest listings first. Each row links to the product’s NDC page.

CELLTRION USA, Inc. NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
Omlycloomalizumab-igecOmalizumab 75 mg/.5mLInjectionSubcutaneous72606-03572606-0035-01—
Omlycloomalizumab-igecOmalizumab 150 mg/mLInjectionSubcutaneous72606-03672606-0036-01—
Omlycloomalizumab-igecOmalizumab 300 mg/2mLInjectionSubcutaneous72606-05472606-0054-0172606-0054-02—
Steqeymaustekinumab-stbaUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneous72606-06072606-0060-01J3357
AvtozmatocilizumabTocilizumab 162 mg/.9mLInjection, SolutionSubcutaneous72606-04572606-0045-0172606-0045-0272606-0045-03+3 more—
AvtozmatocilizumabTocilizumab 80 mg/4mLInjection, SolutionIntravenous72606-04272606-0042-0172606-0042-02—
AvtozmatocilizumabTocilizumab 200 mg/10mLInjection, SolutionIntravenous72606-04372606-0043-0172606-0043-02—
AvtozmatocilizumabTocilizumab 400 mg/20mLInjection, SolutionIntravenous72606-04472606-0044-0172606-0044-02—
Denosumab-BMWODenosumab 60 mg/mLInjectionSubcutaneous72606-05872606-0058-01J0897
Denosumab-BMWODenosumab 120 mg/1.7mLInjectionSubcutaneous72606-05972606-0059-01J0897
Stoboclodenosumab-bmwoDenosumab 60 mg/mLInjectionSubcutaneous72606-03772606-0037-01J0897
Osenveltdenosumab-bmwoDenosumab 120 mg/1.7mLInjectionSubcutaneous72606-03872606-0038-01J0897
Steqeymaustekinumab-stbaUstekinumab 45 mg/.5mLInjection, SolutionSubcutaneous72606-02772606-0027-01J3357
Steqeymaustekinumab-stbaUstekinumab 90 mg/mLInjection, SolutionSubcutaneous72606-02872606-0028-01J3357
Steqeymaustekinumab-stbaUstekinumab 130 mg/26mLInjection, SolutionIntravenous72606-02972606-0029-01—
Zymfentrainfliximab-dyyb—Kit72606-02572606-0025-0172606-0025-0272606-0025-03+9 more—
Zymfentrainfliximab-dyybInfliximab-dyyb 120 mg/mLInjectionSubcutaneous72606-04772606-0047-01—
Adalimumabadalimumab-aaty—Kit72606-02272606-0022-0172606-0022-0272606-0022-03+9 more—
Adalimumabadalimumab-aaty—Kit72606-04072606-0040-0172606-0040-0272606-0040-03+3 more—
Adalimumabadalimumab-aaty—Kit72606-04172606-0041-01—
Yuflymaadalimumab-aaty—Kit72606-02372606-0023-0472606-0023-07—
Yuflymaadalimumab-aaty—Kit72606-03072606-0030-0672606-0030-0972606-0030-10—
Vegzelmabevacizumab-adcdBevacizumab 100 mg/4mLInjection, SolutionIntravenous72606-01172606-0011-0172606-0011-10J9035
Vegzelmabevacizumab-adcdBevacizumab 400 mg/16mLInjection, SolutionIntravenous72606-01272606-0012-0172606-0012-10J9035

CELLTRION USA, Inc.: common questions

What is CELLTRION USA, Inc.'s NDC labeler code?
72606. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for CELLTRION USA, Inc.?
Med-Code's HCPCS directory matches J3357, J0897, J9035 to these products. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in